Cardiovascular magnetic resonance parametric mapping in the risk stratification of patients affected by chronic

Davide Vignale1,2, Elisa Bruno1,2, Anna Palmisano1,2

  • 1Experimental Imaging Center, IRCCS San Raffaele Scientific Institute, Milan, Italy.

European Radiology
|July 29, 2024
PubMed

Insights

Cardiovascular magnetic resonance (CMR) mapping accurately predicts outcomes in chronic myocarditis patients. The intensity of myocardial damage, combined with left ventricle dysfunction, significantly improves risk stratification for heart failure and arrhythmias.

Area of Science:

  • Cardiology
  • Radiology
  • Medical Imaging

Background:

  • Chronic myocardial inflammation is a significant cause of morbidity and mortality, often leading to arrhythmias and dilated cardiomyopathy.
  • Cardiovascular magnetic resonance (CMR) is the gold standard for detecting myocardial inflammation using sensitive parametric mapping techniques.
  • The prognostic value of CMR mapping in chronic myocarditis remains understudied.

Purpose of the Study:

  • To evaluate the prognostic capabilities of CMR parametric mapping in patients with chronic myocarditis.
  • To assess if quantitative analysis of CMR mapping parameters can improve risk stratification.

Main Methods:

  • Retrospective study of 88 patients with suspected chronic myocarditis undergoing CMR (Sept 2017 - Nov 2021).
  • CMR imaging followed 2018 Lake Louise Criteria.
  • Outcomes included heart failure, chest pain, ICD/PM implantation, and arrhythmias (Lown class ≥2).
  • Multivariate logistic regression models incorporating extent/intensity of T1, T2, and ECV alterations, with/without LVEF, were used for prediction.

Main Results:

  • 35% of patients experienced adverse outcomes after a median 21-month follow-up.
  • A model combining mapping alterations' extent and LV dysfunction showed good predictability (AUC 0.71).
  • A model incorporating mapping alterations' intensity and LV dysfunction demonstrated very good performance (AUC 0.80).

Conclusions:

  • Quantitative CMR mapping parameters reflecting myocardial damage severity enhance risk stratification in chronic myocarditis.
  • Intensity of myocardial damage (native T1, T2, ECV alterations) and LV dysfunction improve patient risk stratification.
  • Prospective studies are needed for clinical validation.
Abstract

Related Concept Videos

Imaging Studies for Cardiovascular System IV: CMRI01:21

Imaging Studies for Cardiovascular System IV: CMRI

Cardiovascular magnetic resonance imaging, or CMRI, is a non-invasive diagnostic test that employs a magnetic field and radiofrequency waves to create precise images of the heart and arteries. It provides comprehensive information about cardiac anatomy, function, perfusion, and tissue characterization without ionizing radiation.IndicationsCMRI diagnoses various heart conditions, including tissue damage from heart attacks, ischemic heart disease, myocarditis, aortic issues (tears, aneurysms,...
Imaging Studies for Cardiovascular System V: CT01:28

Imaging Studies for Cardiovascular System V: CT

Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...